Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
2.390
+0.070 (3.02%)
At close: Nov 6, 2026, 4:00 PM EST
2.430
+0.040 (1.67%)
After-hours: Nov 6, 2026, 7:57 PM EST
Larimar Therapeutics Employees
Larimar Therapeutics had 71 employees as of December 31, 2025. The number of employees increased by 6 or 9.23% compared to the previous year. That makes Larimar Therapeutics the 33,369th largest employer in the world and 4,367th in the United States.
Employees
71
Change (1Y)
6
Growth (1Y)
9.23%
Revenue / Employee
n/a
Profits / Employee
-$2,431,056
Market Cap
249.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 71 | 6 | 9.23% |
| Dec 31, 2024 | 65 | 23 | 54.76% |
| Dec 31, 2023 | 42 | 16 | 61.54% |
| Dec 31, 2022 | 26 | -5 | -16.13% |
| Dec 31, 2021 | 31 | 3 | 10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| Rocket Pharmaceuticals | 202 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 65 |
| Lexeo Therapeutics | 63 |
| Camp4 Therapeutics | 48 |
| vTv Therapeutics | 26 |
LRMR News
- 3 days ago - Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at the Upcoming International Congress for Ataxia Research - GlobeNewsWire
- 4 days ago - Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference - GlobeNewsWire
- 5 weeks ago - Larimar Therapeutics appoints John Harlow as COO - TheFly
- 5 weeks ago - Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer - GlobeNewsWire
- 7 weeks ago - Larimar Therapeutics assumed with an Outperform at Leerink - TheFly
- 3 months ago - Larimar Therapeutics price target lowered to $11 from $12 at Wedbush - TheFly
- 3 months ago - Larimar Therapeutics reports Q2 EPS (30c), consensus (38c) - TheFly
- 3 months ago - Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update - GlobeNewsWire